Free Trial

Acura Pharmaceuticals (ACUR) Short Interest Ratio & Short Volume

$0.0055
0.00 (0.00%)
(As of 05/22/2024 ET)

Acura Pharmaceuticals Short Interest Data

Current Short Interest
6,300 shares
Previous Short Interest
6,300 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$63.00
Short Interest Ratio
1.8 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
66,350,000 shares
Percentage of Shares Shorted
0.01%
Today's Trading Volume
4,091 shares
Average Trading Volume
3,420 shares
Today's Volume Vs. Average
120%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Acura Pharmaceuticals ?

Sign up to receive the latest short interest report for Acura Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ACUR Short Interest Over Time

ACUR Days to Cover Over Time

ACUR Percentage of Float Shorted Over Time

Acura Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20246,300 shares $63.00 No ChangeN/A1.8 $0.01
4/15/20246,300 shares $17.64 No ChangeN/A1 $0.00
3/31/20246,300 shares $15.75 No ChangeN/A31.5 $0.00
3/15/20246,300 shares $26.46 No ChangeN/A12.6 $0.00
2/29/20246,300 shares $13.23 No ChangeN/A12.6 $0.00
2/15/20246,300 shares $6.30 No ChangeN/A31.5 $0.00
1/15/20246,300 shares $6.93 -1.6%N/A1.1 $0.00
12/31/20236,400 shares $0.00 No ChangeN/A0.7 $0.00
12/15/20236,400 shares $0.00 No ChangeN/A2.7 $0.00
11/30/20236,400 shares $0.00 No ChangeN/A32 $0.00
11/15/20236,400 shares $0.00 No ChangeN/A64 $0.00
10/31/20236,400 shares $0.00 No ChangeN/A1.4 $0.00
10/15/20236,400 shares $2.56 No ChangeN/A10.7 $0.00
9/30/20236,400 shares $2.56 No ChangeN/A32 $0.00
9/15/20236,400 shares $2.56 No ChangeN/A64 $0.00
8/31/20236,400 shares $2.56 No ChangeN/A12 $0.00
8/15/20236,400 shares $2.56 No ChangeN/A10.7 $0.00
7/31/20236,400 shares $3.84 No ChangeN/A1.6 $0.00
7/15/20236,400 shares $1.92 +1.6%N/A0.8 $0.00
6/30/20236,300 shares $1.89 No ChangeN/A5.7 $0.00
6/15/20236,300 shares $315.00 No ChangeN/A1.7 $0.05
5/31/20236,300 shares $315.00 No ChangeN/A4.8 $0.05
5/15/20236,300 shares $315.00 No ChangeN/A12.6 $0.05
4/30/20236,300 shares $315.00 No ChangeN/A63 $0.05
4/15/20236,300 shares $315.00 No ChangeN/A0.1 $0.05
3/31/20236,300 shares $315.00 No ChangeN/A1.4 $0.05
3/15/20236,300 shares $315.00 No ChangeN/A7 $0.05
2/28/20236,300 shares $315.00 No ChangeN/A6.3 $0.05
2/15/20236,300 shares $315.00 No ChangeN/A7.9 $0.05
1/31/20236,300 shares $315.00 No ChangeN/A10.5 $0.05
1/15/20236,300 shares $315.00 No ChangeN/A31.5 $0.05
12/30/20226,300 shares $315.00 No ChangeN/A1.2 $0.05
12/15/20226,300 shares $315.00 -4.6%N/A1.2 $0.05
11/30/20226,600 shares $330.00 -2.9%N/A16.5 $0.05
11/15/20226,800 shares $340.00 No ChangeN/A1 $0.05
10/31/20226,800 shares $34.00 No ChangeN/A3.2 $0.01
10/15/20226,800 shares $34.00 No ChangeN/A8.5 $0.01
9/30/20226,800 shares $68.00 No ChangeN/A68 $0.01
9/15/20226,800 shares $34.00 No ChangeN/A3.8 $0.01
8/31/20226,800 shares $68.00 No ChangeN/A0.1 $0.01
Seven unknown AI stocks that could DOMINATE the next six years. (Ad)

The original “Magnificent Seven” stocks generated 16,800% over the last 20 years. But now a new set of AI stocks is set to take over.

Get the breakdown of this stock from Alex here.
8/15/20226,800 shares $476.00 -37.6%N/A6.2 $0.07
7/31/202210,900 shares $1,199.00 -27.8%N/A0.6 $0.11
7/15/202215,100 shares $7,533.39 -12.7%N/A1.7 $0.50
6/30/202217,300 shares $8,304.00 +16.1%N/A2.4 $0.48
6/15/202214,900 shares $7,077.50 +17.3%N/A5.3 $0.48
5/31/202212,700 shares $6,096.00 -11.8%N/A0.9 $0.48
5/15/202214,400 shares $5,760.00 -53.1%N/A2.8 $0.40
4/30/202230,700 shares $16,271.00 +25.8%N/A3.8 $0.53
4/15/202224,400 shares $12,078.00 -38.7%N/A1.2 $0.50
3/31/202239,800 shares $15,721.00 -34.3%N/A4.1 $0.40
3/15/202260,600 shares $24,240.00 -3.4%N/A11 $0.40
2/28/202262,700 shares $26,961.00 +21.5%N/A2 $0.43
2/15/202251,600 shares $23,220.00 +35.8%N/A7.6 $0.45
1/31/202238,000 shares $14,478.00 +10.5%N/A1.5 $0.38
1/15/202234,400 shares $18,576.00 +52.2%N/A3.5 $0.54
12/31/202122,600 shares $11,300.00 +117.3%N/A0.9 $0.50
12/15/202110,400 shares $5,694.00 No ChangeN/A0.6 $0.55
11/30/202110,400 shares $5,616.00 -1.0%N/A1 $0.54
11/15/202110,500 shares $5,827.50 -19.2%N/A0.3 $0.56
10/29/202113,000 shares $7,150.00 +25.0%N/A0.8 $0.55
10/15/202110,400 shares $5,928.00 No ChangeN/A0.9 $0.57
9/30/202110,400 shares $5,475.60 No ChangeN/A1.5 $0.53
9/15/202110,400 shares $5,876.00 No ChangeN/A1 $0.57
8/31/202110,400 shares $6,136.00 No ChangeN/A1.4 $0.59
8/13/202110,400 shares $6,654.96 -13.3%N/A0.5 $0.64
7/30/202112,000 shares $7,200.00 -8.4%N/A0.6 $0.60
7/15/202113,100 shares $8,515.00 +24.8%N/A0.6 $0.65
6/30/202110,500 shares $6,930.00 -3.7%N/A0.2 $0.66
6/15/202110,900 shares $5,995.00 +4.8%N/A0.2 $0.55
5/28/202110,400 shares $3,744.00 No ChangeN/A1.2 $0.36
5/14/202110,400 shares $3,829.80 No ChangeN/A1.2 $0.37
4/30/202110,400 shares $4,134.00 No ChangeN/A0.6 $0.40
4/15/202110,400 shares $3,328.00 No ChangeN/A1.9 $0.32
3/31/202110,400 shares $3,432.00 No ChangeN/A1.1 $0.33
3/15/202110,400 shares $3,328.00 No ChangeN/A0.7 $0.32
2/26/202110,400 shares $4,149.60 -5.5%N/A0.5 $0.40
2/12/202111,000 shares $4,240.50 -60.6%N/A0.1 $0.39
1/29/202127,900 shares $6,138.00 +31.0%N/A0.8 $0.22
1/15/202111,200 shares $2,576.00 +7.7%N/A0.7 $0.23
12/31/202010,400 shares $1,882.92 -7.1%N/A0.4 $0.18
12/15/202011,200 shares $2,587.20 +7.7%N/A0.7 $0.23
11/30/202010,400 shares $2,600.00 -65.7%N/A0.6 $0.25
11/15/202030,300 shares $7,575.00 +154.6%N/A1.6 $0.25
10/30/202011,900 shares $2,764.37 -7.0%N/A0.6 $0.23
10/15/202012,800 shares $3,264.00 +23.1%N/A2.2 $0.26
9/30/202010,400 shares $2,600.00 No ChangeN/A0.9 $0.25
9/15/202010,400 shares $2,704.00 -28.8%N/A0.9 $0.26
8/31/202014,600 shares $3,854.40 -16.1%N/A1.8 $0.26
8/14/202017,400 shares $5,014.68 -1.1%N/A1.2 $0.29
7/31/202017,600 shares $4,796.00 +12.1%N/A1 $0.27
Who are Nvidia’s Silent Partners? (Ad)

Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.

I call these Nvidia’s “Silent Partners.”
7/15/202015,700 shares $4,867.00 +51.0%N/A1.5 $0.31
6/30/202010,400 shares $3,640.00 No ChangeN/A1.4 $0.35
6/15/202010,400 shares $3,432.00 -18.1%N/A0.8 $0.33
5/29/202012,700 shares $4,826.00 -58.1%N/A0.4 $0.38
5/15/202030,300 shares $9,544.50 -14.9%N/A1.5 $0.32
4/30/202035,600 shares $12,104.00 +93.5%N/A0.8 $0.34
4/15/202018,400 shares $5,888.00 +17.2%N/A3.6 $0.32
3/31/202015,700 shares $4,396.00 +38.9%N/A0.9 $0.28
3/13/202011,300 shares $3,390.00 -5.0%N/A0.6 $0.30
2/28/202011,900 shares $2,737.00 -8.5%N/A0.5 $0.23
2/14/202013,000 shares $5,200.00 -9.7%N/A3.9 $0.40
1/31/202014,400 shares $4,320.00 +38.5%N/A1.9 $0.30
1/15/202010,400 shares $2,912.00 No ChangeN/A0.7 $0.28
12/31/201910,400 shares $4,160.00 -26.8%N/A0.4 $0.40

ACUR Short Interest - Frequently Asked Questions

What is Acura Pharmaceuticals' current short interest?

Short interest is the volume of Acura Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 6,300 shares of ACUR short. Learn More on Acura Pharmaceuticals' current short interest.

What is a good short interest ratio for Acura Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACUR shares currently have a short interest ratio of 2.0. Learn More on Acura Pharmaceuticals's short interest ratio.

How does Acura Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Acura Pharmaceuticals: NovAccess Global Inc. (0.01%), GelStat Corp. (0.00%), Predictive Technology Group, Inc. (0.00%), Aptevo Therapeutics Inc. (16.76%), Adhera Therapeutics, Inc. (0.00%), Skinvisible, Inc. (0.05%), GlobeStar Therapeutics Co. (0.00%), China SXT Pharmaceuticals, Inc. (2.63%), Aditxt, Inc. (8.48%), RespireRx Pharmaceuticals Inc. (0.01%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Acura Pharmaceuticals stock?

Short selling ACUR is an investing strategy that aims to generate trading profit from Acura Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Acura Pharmaceuticals?

A short squeeze for Acura Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACUR, which in turn drives the price of the stock up even further.

How often is Acura Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACUR, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:ACUR) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners